We didn’t expect to see Abbott at CES 2019, since the show trends toward consumer oriented technologies. But modern glucometers, for example, are some of the most advanced personal electronic devices that people use on a daily basis.
Abbott has been a leader in this field and it has allowed diabetic patients a new level of freedom and safety when using the company’s FreeStyle Libre glucose monitoring system, which continuously measures glucose for two weeks straight. The system consists of disposable stick on patches that feature an almost painless microneedle. A reader that looks like a smartphone is used to download data from the patches. There’s no need to prick the finger every time a reading is to be taken, which alleviates probably the main complaint of people having to closely monitor their glucose.
Here’s our interview with senior director of Digital Platforms for Abbott’s diabetes care business Joel Goldsmith at CES 2019:
Flashbacks: Abbott’s FreeStyle Libre 14 Day Flash Glucose Monitor Approved in U.S…; Abbott’s New FreeStyle Libre 2 Continuous Glucometer with Level Alarms Cleared in EU…; FDA Approves Abbott FreeStyle Libre Flash, a CGM That Requires No Blood Sample Calibration…; Abbott’s FreeStyle Libre Pro Continuous Glucometry System for Professionals FDA Approved…; Abbott FreeStyle Libre Flash Continuous Glucose Monitoring System…
